Evidence map›Paper›PMID 30359225›Full record

ArticleBMC gastroenterology2018

Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.

Jesús-Miguel Herrero, Pablo Vega, María Salve, Luis Bujanda, Joaquín Cubiella

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Diagnosing colorectal cancer in primary care: cohort study in Sweden of qualitative faecal immunochemical tests, haemoglobin levels, and platelet counts.The British journal of general practice : the journal of the Royal College of General Practitioners · 2020
    Article
  13. A risk-stratified approach to colorectal cancer prevention and diagnosis.Nature reviews. Gastroenterology & hepatology · 2020
    Review
  14. Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jesús-Miguel HerreroDepartment of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.
Pablo VegaDepartment of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.
María SalveDepartment of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.
Luis BujandaDonostia Hospital, Biodonostia Institute, University of the Basque Country UPV/EHU, CIBERehd, San Sebastian, Spain.
Joaquín CubiellaDepartment of Gastroenterology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. joaquin.cubiella.fernandez@sergas.es.ORCID http://orcid.org/0000-0002-9994-4831
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversity of the Basque Country · ES

Funding

Instituto de Salud Carlos III PI11/00094
6 · The paper itself

Abstract

backgroundSymptom based referral criteria for colorectal cancer (CRC) detection are the cornerstone of the strategy to improve prognosis in CRC. In 2017, the National Institute for Health and Care Excellence (NICE) updated their referral criteria (2017 NG12). Recently, several studies have evaluated the faecal haemoglobin (f-Hb) concentration in this setting. The aim of this study is to evaluate the diagnostic accuracy of the 2017 NG12 referral criteria and to compare them with the CG27 referral criteria, the f-Hb concentration and two f-Hb based prediction model: COLONPREDICT and FAST Score.

methodsThis is a post-hoc diagnostic test study performed within the COLONPREDICT study database (1572 patients, CRC prevalence 13.6%). We assessed symptoms, the 2017 NG12 and CG27 referral criteria and determined the f-Hb before performing a colonoscopy. We compared the discriminatory ability using the area under the curve (AUC) and the sensitivity and specificity at pre-stablished thresholds with the McNemar's test.

resultsThe 2017 NG12 referral criteria discriminatory ability (AUC 0.53; 95% confidence interval- CI 0.49-0.57) was inferior to the CG27 version (AUC 0.59; 95% CI 0.55-0.63; p = 0.01), the f-Hb concentration (AUC 0.86; 95% CI 0.84-0-89; p < 0.001), the COLONPREDICT Score (AUC 0.92; 95% CI 0.91-0.94; p < 0.001) or the FAST Score (AUC 0.87; 95% CI 0.85-0.89; p < 0.001). The number of patients meeting each criteria were as follows: 2017 NG12 and CG27 = 94.1% and 52.2%; f-Hb ≥20 and ≥ 10 μg/g faeces = 38.6 and 44.3%; COLONPREDICT Score ≥ 5.6 and ≥ 3.2 = 29.4 and 63.2% and FAST Score ≥ 4.50 and ≥ 2.12 = 37.1 and 87.0%. The 2017 NG12 criteria were more sensitive (100%) than the CG27 criteria (68.2%), the f-Hb (≥20 μg/g) (91.2%), the f-Hb (≥10 μg/g) (93.5%), the COLONPREDICT Score (≥5.6) (90.1%) and the FAST Score (≥4.50) (89.8%) (p ≤ 0.001) and equivalent to the COLONPREDICT Score (≥3.5) (99.5%) or the FAST Score (≥2.12) (100.0%) (p = 1). However, their specificity (6.8%) was significantly lower than any of the evaluated criteria (50.3%, 69.6%, 63.4%, 78.7%, 45.8%, 71.3%, 13.9%; p < 0.001).

conclusionReferral criteria based on f-Hb measurement, either as a single test or within prediction models, are more accurate than symptom-based referral criteria for CRC detection in symptomatic patients.

Indexed as

Referral and ConsultationAdultArea Under CurveColorectal NeoplasmsEarly Detection of CancerFecesFemaleHemoglobinsHumansImmunochemistryMaleMiddle AgedPredictive Value of TestsSensitivity and SpecificityHemoglobinsColorectal cancerDiagnostic accuracyFaecal immunochemical testRisk stratification

Identifiers

PMID30359225
PMCPMC6203209
OpenAlexW2898436077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.